Brad Hightower

Note to File: A Clinical Research Podcast

Business EN ↓ 124 episodes

Note to File is a podcast for clinical research sites - interviews, best practices, and candid commentary from Brad Hightower, founder of Hightower Clinical and clinical research professional.

Be sure to visit the podcast's website and support the creator: notetofilepodcast.com

Author

Brad Hightower

Category

Business

Podcast website

notetofilepodcast.com

Latest episode

Aug 11, 2026

Where to listen?

Podcasts in the app Replaio Radio Coming soon

Podcasts are coming to the app soon. Install now and be the first to see a whole new take on podcasts

Get it on Google Play Install for free Android 10M+ downloads · 4.7+ rating iOS soon

Episodes

Wearables, Wagers, and White House Hype 11.08.2026

Note to File gets extra spicy on this one. Brad and Denali riff on everything from wearables and brain health studies to the White House's new "Science: A New Golden Age" report and why U.S. clinical trials are still so painfully slow, expensive, and overburdened.   They dig into:   - Why consumer wearables like Oura and Whoop still aren't meaningfully integrated into most trials   - The gap betwe...

The Ugly Truth About Site Budgets, IWOs, and "Free" Trial Support with Daniel Fox 10.08.2026

Clinical trial sites are leaking money, often without even realizing it. In this episode of Note to File, Denali and Brad sit down with Dr. Daniel Fox of CRPN (Clinical Research Payment Network) to unpack the ugly truth about site finances, brutal IWOs, "free" trial coaches, and why so many sites end up doing work for zero pay. From unscheduled visits that never get reimbursed to vague CTAs that s...

Anthony Corso on FDA, Trialblazer, and the Policy War Over Clinical Trials 07.08.2026

What happens when DC policy, FDA buzzwords, and real-world site pain all collide? In this episode, Brad and Denali sit down with Anthony Corso, VP of Public Policy at Veeva, to unpack the chaos and opportunity in today's "clinical research renaissance." We dig into:   - Real-time clinical trials and the mysterious rise (and fizzle?) of the FDA's Trialblazer initiative   - Why "real-time" safety da...

Why Sites Suck at Recruitment (And How To Fix It) 06.08.2026

From National Mac & Cheese Day to the broken economics of centralized recruitment… this Sticky Notes episode goes from nonsense to nuclear takes on how sites really handle patient recruitment. Denali and Brad dig into why so many sites are drowning in bad referrals, buried in tools, and still treating recruitment like a side quest instead of a core competency. They challenge the idea that sponsors...

Inside the Clinical Research Site Collective: Why Sites Need a Real Advocate with Maria Ladd 05.08.2026

Clinical research sites are *quietly holding all the cards*—so why are they still struggling for support, fair budgets, and real partnership? In this episode of **Note to File**, Brad and Denali sit down with **Maria P. Ladd**, self-declared **Clinical Research Site Advocate** and co-founder of the **Clinical Research Site Collective**, to dig into the gap between sites, CROs, sponsors, and IRBs—a...

Diversity Mandates, Medicare Chaos, and Why Independent Sites Get the Hard Trials 04.08.2026

In this episode of **Note to File**, Brad and Denali dig into:   - **Why independent sites get boxed out** of imaging, colonoscopy suites, and other hospital-owned services   - How **legal, IRB, compliance, and procurement** teams quietly kill otherwise great trials   - The ugly reality of **Medicare coverage analysis**, double billing risk, and why millions go *unbilled* out of fear   - The lates...

Operation "Trial" Blazer: Will It Actually Fix Clinical Research? 03.08.2026

World UFO Day, disco, and…Operation *Trial* blazer?   In this episode of **Note to File**, Brad and Denali kick things off with some classic nonsense—World UFO Day, Roswell, National Disco Day, and why U.S. soccer fandom magically appears every four years—before diving into a serious (and pretty spicy) breakdown of **clinical trial access, economics, and Operation Trailblazer**. We unpack:   - Why...

Capitalism, China & Clinical Trials: Follow the Spreadsheet 02.08.2026

Is "innovation" in clinical trials just a cover for offshoring risk and cozy politics?   In this episode of **Note to File**, Brad and Denali dive into two big stories shaping clinical research right now:   1. **Congress vs Big Pharma in China**      - US House subcommittee letters to Merck, AbbVie, Lilly, Pfizer & more      - Early-phase trials in **Chinese military hospitals**      - Alleged **i...

Small Sites, Big Tech, and the AI Hype Train in Clinical Trials 01.08.2026

Are we actually innovating in clinical research… or just slapping AI buzzwords on old problems? In this episode of Note to File, we go deep on: Founder-led vs board-appointed CEOs – why "benevolent dictators" might actually get more done Why eccentric weirdos sometimes make the best leaders (and the worst coworkers) The wave of AI-in-clinical-research announcements (Florence, EISF, "chat with your...

I Registered a Fake Trial on ClinicalTrials.gov 31.07.2026

Ever wondered how hard it really is to spin up a trial on ClinicalTrials.gov? In this episode of Note to File, Brad and Denali walk through Brad's experiment: he created and submitted a trial record on ClinicalTrials.gov just to see how far it would go. Spoiler: it got published… and the feedback was mostly about formatting, not scientific or ethical rigor. We unpack: 🧾 How easy it is to create a...

eSource, Paper, and AI Slop: A Site-First Reality Check with Oliver Keh 30.07.2026

Clinical trial sites are drowning in double data entry, eSource chaos, and bad software that nobody actually wants to use. In this episode of Note to File, Brad and Denali sit down with Oliver Keh, founder of Gleam, to talk about how his team is attacking data entry and QC from a site-first perspective—no forced sponsor rollout, no "move fast and break GCP" nonsense. We get into: Why data entry is...

Clinical Trials or Casino? FDA Bets, Seeding Trials & Site Survival 29.07.2026

In this Sticky Notes episode, we riff on everything from clinical trial prediction markets (yes, literally betting on FDA approvals) to the murky world of seeding trials that look a lot more like marketing campaigns than science. We dig into: End Point Arena & trial prediction markets – paper trading today, real money tomorrow? How investors already "bet" on trial outcomes by mining clinical data...

Why EU Sites Feel Different: Workweeks, National Health Systems & Real-World Data 28.07.2026

Ever wondered what's REALLY happening with your pharmacy data, how EU sites operate compared to the U.S., or whether you actually need $1.5M to start a research site? In this episode of Note to File, Brad and Denali go full sticky-note mode, bouncing from European work culture to GDPR smackdowns to the future of real‑world data and AI in clinical research. In this episode, we dig into: Copenhagen...

Can We Standardize Clinical Trial Data Like Air Traffic Control? 27.07.2026

In this episode of Note to File, Brad catches up with Denali live from Copenhagen as she kicks off the Veeva EU Summit—their first year meaningfully bringing sites into the mix. They dig into: -How the EU site landscape really compares to the US -Whether sites and sponsors are actually more collaborative in Europe -Why M&A and site networks look different across the pond -And the big one: what air...

Skinny Migraine Patients Only? The Ethics of 'Unicorn' Trial Design 24.07.2026

Clinical trials are supposed to be science… but are they really? In this episode of Note to File, Denali and Brad riff on everything from Veeva's EU R&D Summit in Denmark to patient recruitment reality vs. industry fantasy, and end up in a pretty honest place: We're designing protocols for patients who don't exist. We dig into: -Veeva EU R&D Summit & "site day zero" -Site–sponsor collaboration in...

Joe O'Rourke: Private Equity, Retail Pharmacies & The Future of Research Sites 23.07.2026

The retail pharmacy revolution in clinical trials didn't exactly go as advertised. So what actually happened inside Walgreens, and what does it mean for sites? In this episode of Note to File, Brad and Denali sit down with Joe O'Rourke to unpack the real story behind retail pharmacies in clinical research – what worked, what didn't, and why traditional sites are still carrying most of the load. We...

WHO's New GCP Course, China Data Ban & FDA's AI Pilot 22.07.2026

National Tourism Day, a mystery virus on a cruise ship, WHO launches a free clinical trials course, Congress wants to ban China data, and FDA is piloting AI-enabled early phase trials. Light vibes, heavy implications. In this episode, Brad and Denali riff on how all of this actually hits sites, sponsors, and patients: In this episode we cover: WHO's new free, self-paced clinical trials course 4.5...

Over 50% of Sites Are STILL on Paper?! 21.07.2026

Are we seriously still building source from scratch in 2025? In this episode of Note to File, Denali and Brad break down a new Tufts / CRIO paper on how sites actually prepare source and CRFs—and what the data really says about "innovation" in clinical trials. We get into the uncomfortable truth: -54% of sites are still using paper for visit source -Only 16% are using EMR/EHR to capture research d...

Real-Time Clinical Trials: FDA's Big Bet or Big Mess? 20.07.2026

The FDA just announced a bold push for real‑time clinical trials (RTCT) — including proof‑of‑concept studies, a new pilot program, and an RFI on AI-enabled tech to speed up decision‑making. But from the site and operations side, does any of this actually solve the real problems? In this Note to File episode, Denali and Brad dig into: What the FDA actually said in the recent RTCT press conference -...

Can Retail Pharmacies Save Clinical Trials? Walgreens, CVS, Kroger & Reality 17.07.2026

Walgreens is (maybe) pulling back from clinical research. CVS already bailed. Walmart and Kroger dabbled and went quiet. So what happened to the big retail pharmacy clinical trials dream—and what does it say about the future of sites and PE-backed networks? In this episode of Note to File: The Clinical Research Podcast, Denali and Brad dig into the rumors around Walgreens' clinical trial business,...

Interoperability, Incentives & Illusions of Progress in Clinical Trials 16.07.2026

Brad and Denali dive into the messy middle of clinical research tech – where sponsors, vendors, and sites all say they care about user experience and data quality, but nobody really owns the fallout. In this episode, we unpack: -The EDC email from hell: cryptic protocol strings, confusing log-ins, and why sites are constantly asking, "What study is this again?" -How sponsor configuration can make...

Big Paper Wins Again? Sites, eSource, & the Standardization Problem 15.07.2026

Clinical research is out here discovering cutting‑edge therapies… and still arguing about paper vs. electronic systems. Make it make sense. In this episode of Note to File, Denali and Brad get real about why so many sites are still on paper in 2026, what tech vendors get wrong, and why standardization across sponsors, sites, and systems feels like a fantasy. We cover: -Why small and mid‑size sites...

Drowning in data, starving for budget 14.07.2026

In this episode of Note to File, Brad and Denali dig into the messy realities of modern clinical research operations: The growing disconnect between cancer center administration and clinical operations How siloed academic structures make research less efficient (and more frustrating) Sponsors asking for constant E‑source access and screenshots (!?) The coming wave of continuous data streams (EHR,...

Beer, Bots & Bad Interoperability 13.07.2026

National Beer Day, World Health Day… and AI chatbots pre‑screening your patients? In this episode of Note to File, Brad and Denali go from French‑Canadian prog rock and sneaker culture to some very real questions about how AI is creeping into clinical trials. We riff on: 🍺 National Beer Day vs. World Health Day – irony much? 🎸 A bizarre French‑Canadian prog rock duo with masks and microtonal gui...

Who owns eSource? 10.07.2026

Are research sites doing everything twice for no good reason? In this Sticky Notes episode, Denali and Brad get real about eSource, EDC, and who should actually own site-facing tech. They move past the buzzwords and tackle the uncomfortable questions: Why is sponsor tech so fragmented for sites? If we're already entering everything into EDC, why do we still need separate source? Why isn't direct d...

Listen to the Note to File: A Clinical Research Podcast podcast in Replaio

Radio and podcasts in one app - free, with no sign-up. Install today and do not miss the launch

Get it on Google Play

Replaio is not a podcast publisher; show names, artwork and audio belong to their authors and are distributed through public RSS feeds.